dmagee we were 5 odd a few days ago. anyone that bought then (i did btw) has made over 50%. If that is a boring week to you. I will take it every week. News is what is needed. But as the saying goes. buy on rumours. sell on news.
I am here for the dam drill. I have waited so long , I feel no point not. As I said. Any sniff of a rig this year. this will be pennies, regardless of any dilution.
That is over a 10 bag from where we are. patience if you are an investor. If not then a trader be. gla
spooky. the higher it goes, the less the dilution. also look at 88/ykog. we have a lot more proven oil easier to get out in a much better oil country. while I take your point. We do not know what news is coming. Me I think it unfortunatley is normal of oil exploration companies. we do all the hard work. Then a major comes in and buys it.
There is potentially a bill boo in our site. 30 rigs for 30 years worth. That is the prize.. when/if we get a rig . this will be in the pennies . so matters not imo.
mrnation I agree. esp when the POO was low $20 a barrel . was a master stroke imo. more importantly it highlights to me. how good opl226 really is. Let us not forget oml83/87 are all pumping more oil, than they thought they would.
It has always been the magnitude of our site has kept me in.
now we need this prospectus/finance news. Half of me hopes our team might have other news. it is not as though they have not had time on their hands!
think we all agree. a massive back ground buyer/s. what is int now is intereting is copl will be making money on any draw downs. That is why the deal is so so clever. This must link into why we can not buy. the MM must have wind of news. so if (take zak prediction of .2) . they do not want to sell at less than half. but any other news.. we should re rate to another higher level. all feeling really great (for once). just hope news is good. Lets be frank. they have had a lot of time/spoen to many interested parties. Oil rebounding to $40 bo is great news. . perfect storm if art can get this going. any essa good news. spa/pb. we could be off. all while we are priced as a shell
again today. 20 mill available to buy at a massive premium in one hit. Now NT for 1 mill.. even with a 10 mill sale.
i wonder with our new finance suppliers. Is there now more chatter in the city. will explain a lot to me anyway..
with 3 bill shares in issue, one wonders why you can not buy any atm but can sell huge amounts. gla
did you read the last returns or did you miss something. Suggest you re read them. Kissie deal will get closed off. Why? They invest tranalast and spent a fortune.
They could not get it to do. What little nfx and our boffins did. Deliver it into the lungs directly. Their process could not.
Of course they want it. Call Dan as I and many have groupplease.. bonkers mate!
we are fine for cash. There is no need for any raise. We will have sorted kissie out by then or another. One never knows as you said halespur nxp001 might get off a row licensing deal . I do not expect that to be huge as it needs more work to bring to market.
We are in a good position imo. just need corona sorted/world open again. on google tokyo is looking open. i am sure news is on the way. financials must be soon (aug last year )then we will have a clear idea. Be glad we are a low low cost. By my thinking we are ok for cash until next year q1/2. Only expense I can see atm is the tests for 004.
Income from ebers/gov rnd money.
simandou is the same grade but needs a lot less treatment/beneficiation. you just dig it up and ship it to the railway line. Ours is the same size/a lot less expense needed over the infrastructure. Also simandou is is several clusters. it is not one single vien. Why did they pay so much with only 2 bidders. fomo can be the only reason. imo
I agree with the 3/4 billion figures. which has to be cheap for a mine of this size and now with a port/route to market. Esp as that port is leased so lowers any bidders cap ex.
all we can do is wait for any up dates from bod. I am sure it is coming. no ideas of whe but within 3/9 months is my bet. Ore still going up. the chinese will hate lack of supply
agree no easy. think many our the same over the essar issue. well over many issues. we shall see in common sense wins the day. art has often indicated that he felt a deal can be done in podcasts etc.
all such a shame. if essar had been better partners we could be drilling ages ago. less placings etc. dilution. I have averaged down more times than i care to think about. esp in the 0.4 /5 range. gla
lol halespur. with our model (esp if china had paid we would not of needed one in first place)
we get it to where we are with nxp002. Like we did with 001. and do a deal with another pharma to take it further while they get that country . As we know. Same with kissie. If we get many millions there. We are not only fully funded. More imp we can develop 004 to the same stage. Then do a similar deal to take it to human trials.
I really hope we never have another placing. If it was not for non payments, we would not have.
but a sale or say, kissie wanting to buy a % of the company. Would be nice. I know if tranalast was my drug and had spent all that money on it. Knew and understood NXP002 and why it worked, when they failed.
The potential is huge. I would want to have a bite of the company as well.. just my hopes. dare to dream..
noeasy lets remember that essar started it in sept as we ob made them a bad offer to take them out in July. Knowing art prob back end out of oil payments. they started legal work and from what arthur has said, we did a lot of the legal work to defend this then. Essar stopped as they realize we have a potentially winning hand.
While I dislike the essar bully boy tactics. I have never understood why?
They sold it to us as they burnt all their bridges there.
Nigeria dislikes them it seems. They even got aga (no doubt a corrupt ex oil minister). Everything they tried to do was bent it seems. Or not the proper way in Nigeria.
Today I truly hope we are now holding a lot more cards. We shall soon see.
1/ Nigeria would throw essar under a bus
2/ I do not think they will kola
3/ essar have probably been told this. As Nigerians are tribal and Kola /his family are massive there
4/ essar will of said they want their money back then?
5/ Nigeria have prob said , after we have sold it for more. Sort this deal out , or lose out.
6/the surveys they did 30 mill will be lost. plus all other expenses .
In short. I believe the game is up. we all know the oct date can be extended . As most licenses in |Nigeria are well behind and it is the African way. If there is a will to and if progress has been made (again Kola is the key). Art has always said. We hold all the cards. So essar can not take it from us it seems. They have tried to make us bankrupt (thanks, not!)
Even they can not be that blind. They can not force Nigeria to do anything, they are in control. It is their country after all. They do not even have the full legal rights.We do as per the contract we have.
both nxp002/004 will treat different fibrosis . As you see from below they are huge markets. This is how any lth will get their pay day. Ob one has to have patience and understand. Pharma takes a long time as is so regulated (thankfully)
002 will happen once tokyo opens up. (it appears they are now not in lockdown over there). IMO a deal this big needs people at a table. (yes small % chance it does not). We are asking for a lot of money from a billion $$ company.
004. weeks away from seeing how good it is. If like 002 they will be testing it against the performance of other lead drugs.
These 2 together (when assed human trials). Have to make us worth 3/500 million. When I look at other major pharma. They can spend 1 billion developing a drug. 80/90 % fail Many discover other uses when in the trials (viagra was for heart disease, then many men got the obvious reaction)
So this is my thoughts. If we have 2 huge drugs and nxp001/ebers/recent collaboration . Why is 400 mill or more not achievable? I hope for more myself. All this can be 14/24 months away. 80p/£1 ps.
Me I hope we license them out to a major and get an income and develop more. Either way it is a very exciting prospect to me
interesting. zac is predicting a 3 bagger from here. sign off with the prospectus might get us there?. well for what ever reason it is delayed. it seems.
we all know as lth if/when we get SPA/PB etc. then a lot lot higher.. guess thats why we hold..
just dream of a day we have a rig on site.. gla
Nxp004. The AIM-listed firm said the new addition, NXP004, is “based on a recently approved targeted oncology therapy currently experiencing significant sales growth”.
Nuformix told investors it identified an innovative application for NXP004 in a new indication “with high unmet need”.
As per the research, global oncology pharmaceutical market will we worth USD 202.54 billion by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.
Oncology had the largest revenue share in Global pharmaceuticals market in FY 2018, and it is expected to retain in it’s leadership position even in 2023.
This growth in oncology market is fueled by the growing and ageing population in key markets. As per World Population Prospects by United Nations, the worldwide population is likely to cross 9.3 billion by 2050 and around 21% of this population is expected to be aged 60 and above. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families worldwide also is driving the growth of global oncology industry. Another aspect which is leading this growth is rising focus of pharmaceuticals companies to tap the rare and specialty diseases market. Innovations in advanced biologics, nucleic acid therapeutics, cell therapies and bioelectronics & implantables has attracted investments in the industry which is fueling this growth.
On the other hand, adoption of cost control policies along with tightening of rules by governments in key markets are expected to impact the growth prospect of the global oncology industry. Oncology companies are forced to reduce their research and development (R&D) spending due to slowdown of growth in last few years which is also expected to hamper growth of the global oncology market as new drugs revenue form large part of pharma firm’s revenue due to exclusivity of the drug. Apart from this, generics pharma market is facing decreasing return on investment due to price erosion in key markets which is forcing many firms to look for other avenues and markets to sustain growth.
On 3rd January 2019, Bristol-Myers Squibb Company which was ranked 4th based on their FY 2018 oncology revenue announced their plan to acquire Celgene Corporation which was ranked 2nd in the world. The acquisition is expected to cost around USD 90 billion to Bristol-Myers Squibb Company. Post-acquisition Bristol-Myers Squibb Company is expected to give tough competition to Roche Holding AG which is currently world’s top oncology company by FY 2018 revenue.
Spanning over 283 pages and 201 exhibits, “Global Oncology Market Forecast 2023” report provides in-depth analysis for the global oncology pharmaceuticals market for the yea
allthat, a plus 1 share extra holding imo sounds better! he he..
but I agree re glen. they inherited this. it is not there bag. I wish they would change tact. who knows what is going on behind the scenes.
I do disagree on dso. has to be done. If this can be in 2 years. phase 1 is 3/ (later I would guess). So for any JV (where I guess this is aimed). We could be producing income at the same time as building up the full phase 1. Whatever you say it is a fact. The dso has to be removed to get to the first layer of ore.
3/4 mtpa is potentially $300 million pa. I mean if I was investing a lot of money. I would want to see the quickest route to get it back. This is that imo.
they must of been shown a hell of a lot more than we humble PI ever would be. They are in theory agreeing to fund a company in nearly the amount we were worth. give or take a bit.
you do not do that if you have not seen a lot of info. It is also the only deal i can find like this they have done. so a lot must be known imo.
As we are now at 74 thats copl in profit as well. ob they are expecting it a lot higher and must of seen proof imo. to agree to it ..